
JAK Inhibitors: Are All Promises Fulfilled?

Biologic or Conventional Therapy for Early RA?

Phase 2 Study Shows Promising Results for Deucravacitinib in PsA

Baricitinib Promising for Juvenile Idiopathic Arthritis

Study Compares Intra-Articular Morphine with Steroids & Placebo in Patients with Chronic Knee Arthritis

FDA Approves Riabni, a Rituxumab Biosimilar, to Treat Patients with RA

Challenges in Reproductive Health in Rheumatic Disease

The ACR Responds to Reports of Treatment Denials in Wake of Dobbs v. Jackson Women’s Health Organization

ACR-FDA Summit Focuses on Study Design, Safety Considerations
- 1
- 2
- 3
- …
- 120
- Next Page »